Related Experiment Videos
Tumor targeting with a selective gelatinase inhibitor
E Koivunen1, W Arap, H Valtanen
1Department of Biosciences, Division of Biochemistry, Viikinkaari 5, University of Helsinki, FIN-00014, Finland.
Nature Biotechnology
|August 3, 1999
Summary
Researchers discovered specific peptide inhibitors targeting matrix metalloproteinase-2 (MMP-2) and MMP-9. These inhibitors show potential for cancer therapy by blocking tumor growth and metastasis.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- Matrix metalloproteinase (MMP) activity is crucial for tumor growth, angiogenesis, and metastasis.
- Lack of specific inhibitors for MMP-2 and MMP-9 has hindered targeted cancer therapies.
Purpose of the Study:
- To isolate specific inhibitors for the gelatinase family of MMPs (MMP-2 and MMP-9).
- To evaluate the therapeutic potential of these inhibitors in cancer treatment and targeting.
Main Methods:
- Utilized phage display peptide libraries to identify gelatinase inhibitors.
- Synthesized and tested cyclic peptides containing the HWGF sequence for MMP inhibition.
- Assessed peptide efficacy in inhibiting endothelial and tumor cell migration.
- Evaluated tumor growth, invasion, and survival in animal models.
- Investigated phage displaying peptides for targeting angiogenic blood vessels in vivo.
Main Results:
- Isolated cyclic peptides containing the HWGF sequence as potent and selective inhibitors of MMP-2 and MMP-9.
- The synthetic peptide CTTHWGFTLC demonstrated inhibition of human endothelial and tumor cell migration.
- CTTHWGFTLC effectively prevented tumor growth and invasion in animal models, improving survival.
- CTTHWGFTLC-displaying phage specifically targeted angiogenic blood vessels in vivo.
Conclusions:
- Selective gelatinase inhibitors, such as CTTHWGFTLC, can be developed using phage display technology.
- These inhibitors hold promise for targeted cancer therapies by inhibiting tumor progression and angiogenesis.
- Targeted delivery of therapeutic agents via phage displaying specific inhibitors is feasible for anticancer strategies.